{
  "actions": [
    {
      "acted_at": "2018-09-06", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2018-09-06", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s3420-115", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "G000562", 
      "district": null, 
      "name": "Gardner, Cory", 
      "original_cosponsor": true, 
      "sponsored_at": "2018-09-06", 
      "state": "CO", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2018-09-06", 
  "number": "3420", 
  "official_title": "A bill to require the Food and Drug Administration to prioritize the promotional materials for drugs for serious, life-threatening diseases or conditions or substance use disorders, especially opioid drugs and drugs for medication-assisted treatment, in considering whether promotional materials are false or misleading.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Accountability in Opioid Advertising Act", 
  "sponsor": {
    "bioguide_id": "H001075", 
    "district": null, 
    "name": "Harris, Kamala D.", 
    "state": "CA", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2018-09-06", 
  "subjects": [
    "Civil actions and liability", 
    "Consumer affairs", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug therapy", 
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Fraud offenses and financial crimes", 
    "Health", 
    "Marketing and advertising", 
    "Prescription drugs", 
    "Television and film"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to require the Food and Drug Administration to prioritize the promotional materials for drugs for serious, life-threatening diseases or conditions or substance use disorders, especially opioid drugs and drugs for medication-assisted treatment, in considering whether promotional materials are false or misleading.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Accountability in Opioid Advertising Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Accountability in Opioid Advertising Act", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Accountability in Opioid Advertising Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:45:30Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s3420.xml"
}